{"id":5111,"date":"2026-06-11T15:15:46","date_gmt":"2026-06-11T15:15:46","guid":{"rendered":"https:\/\/tradertideinsights.com\/?p=5111"},"modified":"2026-06-11T15:15:46","modified_gmt":"2026-06-11T15:15:46","slug":"nvidia-teams-up-with-abridge-to-build-ai-model-for-healthcare-report","status":"publish","type":"post","link":"https:\/\/tradertideinsights.com\/?p=5111","title":{"rendered":"Nvidia teams up with Abridge to build AI model for healthcare: report"},"content":{"rendered":"
<\/div>\n

Nvidia is expanding its presence in healthcare artificial intelligence through a new partnership with medical technology startup Abridge, as competition intensifies among technology companies seeking to apply AI tools across the healthcare industry.<\/p>\n

According to a report by The Wall Street Journal<\/a>, Nvidia and Abridge are developing an AI model specifically designed for clinical conversations between doctors and patients.<\/p>\n

The model will be deployed exclusively within Abridge’s platform and is intended to improve medical documentation, clinical decision support, and other healthcare workflows.<\/p>\n

Nvidia is already an investor in the Pittsburgh-based startup, which has emerged as one of the leading providers of AI-powered note-taking tools for healthcare professionals.<\/p>\n

Focus on clinical intelligence<\/h2>\n

The new model will be built using Nvidia’s Nemotron family of open AI models and then customized using Abridge’s healthcare expertise and clinical data.<\/p>\n

Kimberly Powell, Nvidia’s vice president of healthcare, said the partnership reflects a broader effort to adapt AI models for specialized industries.<\/p>\n

“There’s an opportunity now to take these models and adapt them with this clinical intelligence at a much earlier stage of model development,” Powell said.<\/p>\n

Unlike general-purpose AI models, the healthcare-focused system is being trained to understand the nuances of doctor-patient interactions, medical terminology and clinical decision-making.<\/p>\n

Powell said the collaboration also demonstrates how Nvidia’s open models can be tailored for sectors such as drug discovery, medical devices, and digital health.<\/p>\n

“Nvidia has been known to be the AI company that works with every other AI company,” Powell added.<\/p>\n

Healthcare becomes the next AI battleground<\/h2>\n

The announcement comes amid a broader race among technology firms to build healthcare-focused AI products.<\/p>\n

Last week, Microsoft unveiled a collaboration with Mayo Clinic aimed at creating a healthcare-specific AI model trained on clinical data.<\/p>\n

OpenAI and Anthropic have also introduced healthcare offerings targeted at both consumers and medical professionals.<\/p>\n

The growing interest reflects the size of the healthcare market and the potential for AI to reduce administrative burdens, improve productivity, and assist with clinical decision-making.<\/p>\n

For Abridge, the partnership offers access to Nvidia’s AI infrastructure while allowing the company to incorporate years of clinical expertise into the model.<\/p>\n

Abridge brings medical data and expertise<\/h2>\n

Abridge plans to use de-identified clinical data gathered through its platform to further train and customize the model.<\/p>\n

“Generic models are powerful, but clinical intelligence it still has to be trained, it has to be shaped, and it has to be evaluated against real-world conditions. That’s a lot of our early experiments and work with the Nemotron team,” said Dr. Shiv Rao, Abridge’s co-founder and chief executive.<\/p>\n

Founded in 2018, Abridge specializes in ambient-listening technology that records conversations between doctors and patients and automatically generates clinical notes.<\/p>\n

The company raised $300 million last year in a funding round that valued it at $5.3 billion, underscoring investor enthusiasm for healthcare AI applications.<\/p>\n

The new model is expected to become one of several AI systems powering Abridge’s platform when it launches later this year.<\/p>\n

According to Davis Liang, Abridge’s director of applied science, the company previously developed its own speech-recognition model because existing third-party systems were not optimized for hospital environments and medical terminology.<\/p>\n

Cost efficiency is another factor driving the partnership.<\/p>\n

Liang said smaller, purpose-built open models are often less expensive than proprietary alternatives and can be deployed on Abridge’s own infrastructure.<\/p>\n

Hospitals see potential beyond documentation<\/h2>\n

Healthcare providers are already exploring how the technology could evolve beyond note-taking.<\/p>\n

Dr. Joon Lee, chief executive of Emory Healthcare, said the health system has rolled out Abridge’s platform to more than 3,000 physicians.<\/p>\n

Lee believes increasingly sophisticated AI tools could eventually provide real-time support during patient consultations.<\/p>\n

“The doctor-patient conversation is at the center of so much decision-making and information exchange,” Lee said.<\/p>\n

“I’m excited about the possibility of intelligence coming more and more in real-time.”<\/p>\n

As healthcare becomes one of the most competitive frontiers for artificial intelligence, Nvidia’s latest partnership signals that the battle for medical AI leadership is only beginning.<\/p>\n

The post Nvidia teams up with Abridge to build AI model for healthcare: report<\/a> appeared first on Invezz<\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Nvidia is expanding its presence in healthcare artificial intelligence through a new partnership with medical technology startup Abridge, as competition intensifies among technology companies seeking to apply AI tools across the healthcare industry.According to a report by The Wall Street Journal, Nvidia and Abridge are developing an AI model specifically designed for clinical conversations between…<\/p>\n","protected":false},"author":1,"featured_media":5112,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-5111","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stock"],"_links":{"self":[{"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=\/wp\/v2\/posts\/5111","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5111"}],"version-history":[{"count":0,"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=\/wp\/v2\/posts\/5111\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=\/wp\/v2\/media\/5112"}],"wp:attachment":[{"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5111"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5111"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradertideinsights.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5111"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}